What are the causes of polycythemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Polycythemia

Polycythemia results from three major categories: apparent (relative) polycythemia due to plasma volume depletion, primary clonal disorders (polycythemia vera), or secondary polycythemia driven by either hypoxia-dependent or hypoxia-independent mechanisms. 1

Apparent (Relative) Polycythemia

This represents a false elevation in hematocrit without true increase in red cell mass:

  • Plasma volume depletion from severe dehydration, diarrhea, vomiting, diuretic use, capillary leak syndrome, or severe burns causes relative polycythemia that is clinically obvious and does not require specialized testing. 1

  • Smoker's polycythemia is a real condition caused by chronic carbon monoxide exposure, which binds hemoglobin with 200-250 times greater affinity than oxygen, creating functional hypoxia; this resolves with smoking cessation. 1, 2

Primary Polycythemia (Polycythemia Vera)

This is a JAK2-mutated myeloproliferative neoplasm representing clonal stem cell disease:

  • Polycythemia vera (PV) is characterized by clonal erythrocytosis with low or inappropriately normal serum erythropoietin (EPO) levels, distinguishing it from secondary causes. 1

  • JAK2 V617F mutation is present in up to 97% of PV cases and should be tested when EPO is low or normal. 1, 2

  • PV is classified as a chronic myeloproliferative disorder along with essential thrombocythemia and myelofibrosis with myeloid metaplasia, representing clonal stem cell disorders. 3

  • The disease often presents with leukocytosis, thrombocytosis, and panmyeloid hyperplasia of the bone marrow, with risks of progression to myelofibrosis or acute leukemia. 3, 4

Secondary Polycythemia: Hypoxia-Driven Causes

These conditions trigger compensatory erythropoiesis through tissue hypoxia:

  • Chronic lung disease (COPD, pulmonary fibrosis) triggers compensatory erythropoiesis through tissue hypoxia. 1, 2

  • Right-to-left cardiopulmonary vascular shunts cause secondary polycythemia due to hypoxia. 1, 2

  • High-altitude habitation leads to physiologic polycythemia as an adaptive response to reduced atmospheric oxygen. 1, 5

  • Carbon monoxide poisoning and chronic exposure in smokers creates functional hypoxia by binding hemoglobin with 200-250 times greater affinity than oxygen. 1, 2

  • Hypoventilation syndromes including obstructive sleep apnea cause chronic intermittent hypoxia leading to compensatory erythrocytosis. 1, 6

Secondary Polycythemia: Hypoxia-Independent Causes

These conditions produce EPO independently of tissue oxygen status:

  • Renal cell carcinoma produces EPO independently of hypoxia and is a major cause of tumor-associated polycythemia. 1, 2

  • Hepatocellular carcinoma produces EPO independently of hypoxia. 1, 2

  • Cerebellar hemangioblastoma produces EPO independently of hypoxia. 1

  • Uterine leiomyomas (benign tumors) can produce EPO. 1

  • Pheochromocytoma can produce EPO. 1

  • Meningioma can produce EPO. 1

  • Post-renal transplant erythrocytosis (PRTE) is a potential cause of secondary polycythemia. 2

  • Exogenous administration of erythropoietic drugs (EPO, androgen preparations) can cause secondary polycythemia. 2

Congenital Causes

These are rare genetic disorders affecting oxygen sensing or hemoglobin function:

  • High oxygen-affinity hemoglobinopathy (congenital, autosomal-dominant) can lead to secondary polycythemia. 2, 5

  • EPOR mutations (some cases of autosomal-dominant congenital polycythemia) can lead to secondary polycythemia. 2, 5

  • Abnormally elevated set point for EPO production and abnormal oxygen homeostasis (Chuvash polycythemia) represent congenital causes. 2, 5

  • 2,3-bisphosphoglycerate mutase deficiency causes congenital polycythemia. 5

  • Von Hippel-Lindau gene mutations can cause disturbances of renal oxygen sensing leading to polycythemia. 5

References

Guideline

Polycythemia Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Secondary Polycythemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Polycythemia vera.

Disease-a-month : DM, 1992

Research

Congenital and acquired polycythemias.

Deutsches Arzteblatt international, 2008

Guideline

Obstructive Sleep Apnea Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.